RPID

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) is a life sciences technology company founded in 2006 and headquartered in Lowell, Massachusetts. Originally incorporated as Genomic Profiling Systems, Inc., the company changed its name to Rapid Micro Biosystems in January 2007 and went public in July 2021. The company specializes in automating microbial quality control testing for pharmaceutical, medical device, and personal care manufacturers through its flagship Growth Direct platform, which modernizes traditional manual testing workflows that have remained largely unchanged for decades.